ASSESSMENT OF A CANADIAN PRIMARY CARE ELECTRONIC MEDICAL RECORD DATABASE FOR USE IN OBSERVATIONAL STUDIES

Author(s)

Frise S*1;Reidel K2;Tarride JE1;Corner N2, Dziarmaga A1 1AstraZeneca Canada Inc., Mississauga, ON, Canada, 2IMS Brogan Canada, Kirkland, QC, Canada

OBJECTIVES: Observational data derived from clinical practice is becoming increasingly important to answer questions that cannot be addressed by RCTs. Although there are a number of administrative databases in Canada, access to more comprehensive, longitudinal clinical data such as smoking status, body weight and laboratory values in the primary care setting is limited. The objective of this study was to evaluate a Primary Care EMR (Electronic Medical Record) system to determine its feasibility for use in observational studies. METHODS: We analyzed de-identified patient data from primary Health Care Professionals (HCPs) including General Practitioners from 2009-2011. Comprehensiveness and completeness of each variable by visit were evaluated. First steps were taken to understand how the patient population compares to data from published sources. RESULTS: There were 3,019,954 patient visits observed by 255,274 active patients (≥1 visit). The patient visits were entered by 497 HCPs (152 physicians). Data are available for demographics, vitals, smoking status, laboratory values, prescriptions, medical history, diagnosis (ICD-9), short term absences and referrals. Completeness of each variable by visit ranged from 26% for pulse to 100% for age, sex, lab results and referrals. Initial assessment revealed that 85.6% of written prescriptions and 88% of diagnoses were recorded using structured fields. The median age of patients in the EMR was 37.2 years compared to 39.9 years reported by Statistics Canada (July 2011). Younger age groups were overrepresented, with the largest difference found in those 20-29 years; no difference was observed for sex. CONCLUSIONS: The status of electronic primary care health records in Canada is still in its infancy. The research suggests this is a valuable new addition to support observational studies in Canada. Disease specific validation studies will be required prior to further analysis. Further research is being undertaken to review quality measures.

Conference/Value in Health Info

2013-11, ISPOR Europe 2013, The Convention Centre Dublin

Value in Health, Vol. 16, No. 7 (November 2013)

Code

PRM45

Topic

Real World Data & Information Systems

Topic Subcategory

Reproducibility & Replicability

Disease

Multiple Diseases

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×